Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…nd Methods For the preparation of a qualification batch, 130 mg losartan potassium (GMP compliant API) were exactly weighted and dissolved in 163 …
…).Conclusion and Relevance The proportion of patients receiving AT within 14 days of death (9.5%) was below the 10% threshold desc…
…CPS-016 Figure 1Carbon footprint savings achieved by delivering outpatient medications to community pharmaciesConclusion and Relevance Delivering outp…
…atient per year.Conclusion and Relevance PK-guided switching to EHL FIX prophylaxis markedly improved all PK parameters while reducing …
…n at discharge ranged €30,074–€337,459.Conclusion and Relevance Oritavancin demonstrated an adequate effectiveness and safety profile with …
… the median age was 50 (16-84) years, 53.1% of whom were women. Risankizumab prescriptions were for: PsO (58.4%), CD (30.1%), PsA (10.6%), a…
…he following CGRP pathway-targeted preventive treatments: 32.4% galcanezumab, 28.1% erenumab, 24.3% fremanezumab, 8.2% atogepant, 2.5% eptin…
…idaemia despite intensive treatment with statins and ezetimibe. Inclisiran, a small interfering ribonucleic acid that inhibits hepatic syn…
…ntial for antibiotics with a narrow therapeutic window, such as linezolid, where subtherapeutic exposure may compromise efficacy and over…
… measured by the reduction in monthly migraine days. To analyse atogepant’s safety, adverse events related to this drug were recorded.Pat…
…bling symptoms, and an increased risk of cardiovascular events. Mavacamten, a selective cardiac myosin modulator, has demonstrated improve…
…ftriaxone and teicoplanin were most used (61 each), followed by levofloxacin (59) and ertapenem (53). Tigecycline was the leading RESERVE an…